Josephine Kanbach
- Department: Clinical Epidemiology
- Unit: Translational Cancer Epidemiology
- since May 2021: Research associate at the Lebniz-Institute for Prevention Research and Epidemiology- BIPS
- 2018- 2021: M.Sc. Epidemiology, University of Bremen
- 2015- 2018: B.A. Public Health, University of Bremen
- 2018- 2021: M.Sc. Epidemiology, University of Bremen
- 2015- 2018: B.A. Public Health, University of Bremen
- Epidemiology of cancer
- Secondary and claims data
- Secondary and claims data
Articles with peer review
- Kanbach J, Rischke N, Luttmann S, Haug U. Exploring the potential of German claims data to identify incident lung cancer patients. BMC Pulmonary Medicine. 2025;25:289.
https://doi.org/10.1186/s12890-025-03740-8 - Rischke N, Kanbach J, Haug U. Age differences in the treatment of lung cancer: A cohort study among 42,000 patients from Germany. Journal of Cancer Research and Clinical Oncology. 2024;150:503.
https://doi.org/10.1007/s00432-024-06025-5 - Rischke N, Kanbach J, Haug U. Utilization of EGFR, ALK, and BRAF inhibitors in the treatment of lung cancer in Germany. Cancer Reports. 2024;7(12):e70060.
https://doi.org/10.1002/cnr2.70060 Presentations at scientific meetings/conferences
- Kanbach J, Rischke N, Luttmann S, Haug U. Exploring the potential of German claims data to identify incident lung cancer patients. "Gesundheit gemeinsam" Kooperationstagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS), Deutschen Gesellschaft für Sozialmedizin und Prävention (DGSMP), Deutschen Gesellschaft für Epidemiologie (DGEpi), Deutschen Gesellschaft für Medizinische Soziologie (DGMS) und der Deutschen Gesellschaft für Public Health (DGPH), 8.-13. September 2024, Dresden.
Selected BIPS-Publications
For further publications please follow this link:
The responsibility for the content of this page lies with Josephine Kanbach.
